Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asia
Pharma
Samsung Biologics bags $1.2B production contract
Samsung has locked down a $1.2 billion contract with an unnamed Asia-based pharmaceutical company that’s expected to run through December 2037.
Fraiser Kansteiner
Oct 22, 2024 10:02am
Gilead leads Asian patient groups' drugmaker reputation rankings
Sep 25, 2024 10:40am
Kyowa Kirin trims small molecule research, Asian operations
Aug 1, 2024 2:06pm
Novo teams up with Indonesian firm on insulin pact
Jul 10, 2024 10:58am
Lotte Biologics breaks ground on $3.3B Korean production plant
Jul 8, 2024 2:55pm
China's Hengrui hit with Form 483 for manufacturing shortfalls
Jun 6, 2024 9:29am
